BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2298625)

  • 21. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).
    Cozzarini C; Fiorino C; Ceresoli GL; Cattaneo GM; Bolognesi A; Calandrino R; Villa E
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):688-94. PubMed ID: 12573756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications.
    Han BH; Wallner KE
    Int J Cancer; 2001 Dec; 96(6):372-8. PubMed ID: 11745508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probability of late rectal morbidity in 125I prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):342-53. PubMed ID: 12527047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.
    Skwarchuk MW; Jackson A; Zelefsky MJ; Venkatraman ES; Cowen DM; Levegrün S; Burman CM; Fuks Z; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):103-13. PubMed ID: 10758311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects.
    Kishan AU; Kupelian PA
    Brachytherapy; 2015; 14(2):148-59. PubMed ID: 25516492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of radiation-induced gastrointestinal morbidity: A prospective, longitudinal study following radiotherapy for carcinoma of the prostate.
    Yeoh EK; Krol R; Dhillon VS; Botten R; Di Matteo A; Butters J; Brock AR; Esterman A; Salisbury C; Fenech M
    Acta Oncol; 2016 May; 55(5):604-10. PubMed ID: 27046049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.
    Elsayed H; Bölling T; Moustakis C; Müller SB; Schüller P; Ernst I; Willich N; Könemann S
    Strahlenther Onkol; 2007 Nov; 183(11):617-24. PubMed ID: 17960337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer.
    Huang EY; Lin H; Hsu HC; Wang CJ; Chen HC; Sun LM; Hsiung CY
    Gynecol Oncol; 2000 Dec; 79(3):406-10. PubMed ID: 11104610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.
    Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G
    Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
    Zapatero A; García-Vicente F; Modolell I; Alcántara P; Floriano A; Cruz-Conde A; Torres JJ; Pérez-Torrubia A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1343-51. PubMed ID: 15275719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
    Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
    Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer.
    Lee J; Han HJ; Min BS; Hong SP; Shin SJ; Yoon HI; Park SJ; Koom WS
    Jpn J Clin Oncol; 2018 Nov; 48(11):988-994. PubMed ID: 30239826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.
    Hamlett LJ; McPartlin AJ; Maile EJ; Webster G; Swindell R; Rowbottom CG; Choudhury A; Aitkenhead AH
    Br J Radiol; 2015 Oct; 88(1054):20150110. PubMed ID: 26246172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of early proctoscopy in predicting late symptomatic proctitis after external radiation therapy for prostate carcinoma.
    Campostrini F; Musola R; Marchiaro G; Lonardi F; Verlato G
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1031-7. PubMed ID: 22975612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence and clinical consequences of treatment-related bowel injury.
    Miller AR; Martenson JA; Nelson H; Schleck CD; Ilstrup DM; Gunderson LL; Donohue JH
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):817-25. PubMed ID: 10098437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis.
    O'Brien PC; Franklin CI; Dear KB; Hamilton CC; Poulsen M; Joseph DJ; Spry N; Denham JW
    Radiother Oncol; 1997 Nov; 45(2):117-23. PubMed ID: 9424000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer.
    Kupelian PA; Willoughby TR; Reddy CA; Klein EA; Mahadevan A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1146-50. PubMed ID: 17919834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis.
    Teh BS; Mai WY; Uhl BM; Augspurger ME; Grant WH; Lu HH; Woo SY; Carpenter LS; Chiu JK; Butler EB
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):705-12. PubMed ID: 11172952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.